Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile
- 4 August 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (5) , 384-390
- https://doi.org/10.1161/circulationaha.108.835470
Abstract
Background— An updated Framingham risk prediction tool was recently published. It features an expanded end point of general cardiovascular disease and a “vascular age” risk communication analogy. Methods and Results— We systematically examined the tool to determine which risk factor combinations allow risk thresholds to be reached and how different risk factor burdens translate into vascular age. We varied risk factor levels in isolation and combination and observed risk output patterns, with high risk defined as ≥20% 10-year predicted risk. As expected, we found that age is the major determinant of 10-year predicted risk for both men and women. Younger individuals tend not to exceed 20% 10-year risk even with multiple risk factors, although with marked risk factor burden, including both smoking and diabetes mellitus, men as young as 35 years of age and women as young as 40 years of age can be classified as high risk. For the risk factor levels we entered, predicted risk ranges from 3.1% to 46.8% for a 45-year-old man and 2.4% to 42.7% for a 55-year-old woman. Likewise, vascular age ranges from 37 to >80 years for a 45-year-old man and 39 to >80 years for a 55-year-old woman. Conclusions— The inclusion of noncoronary end points in this tool expands the range of predicted risks for men and women at all ages studied. Nevertheless, many younger individuals with high risk factor burden have low 10-year predicted risk. Wide ranges of “vascular age” are available for most chronological ages to assist with risk communication.Keywords
This publication has 22 references indexed in Scilit:
- Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment toolPreventive Medicine, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- European PerspectivesCirculation, 2008
- Framingham risk score and prediction of coronary heart disease death in young menAmerican Heart Journal, 2007
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 UpdateCirculation, 2007
- National Cholesterol Education Program risk assessment and potential for risk misclassificationPreventive Medicine, 2006
- Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication StrategiesAnnals of Family Medicine, 2006
- Novel Approach to Examining First Cardiovascular Events After Hypertension OnsetHypertension, 2005
- Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?Heart, 2005
- Framingham risk score and prediction of lifetime risk for coronary heart diseaseThe American Journal of Cardiology, 2004